Multiplexed assays for AKT/m TOR pathway - phase i sbir topic 271
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201000105C
- Awardee
-
Rockland Immunochemicals Inc. UEI NFKNUGEMMY18
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,937
Award facts
- Opportunity
-
- PHS20101 Solicitation number
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Award Notice · Posted Aug 4, 2009
- Contract value 100% obligated
- $149,937.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boyertown, PA 19512, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $149,937 |
About this award
The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), awarded a $149,937 Small Business Innovation Research (SBIR) Phase I contract to Rockland Immunochemicals Inc., a for-profit manufacturer and S Corporation, to develop lyophilized (freeze-dried) guinea pig complement with diluent. The contract, awarded on September 30, 2010, has a completion date of August 30, 2011. Rockland Immunochemicals has also previously served as a subcontractor to the prime contractor Leidos Biomedical Research Inc., providing monoclonal antibodies, antibody production, and related services for other federal contracts.
Quick answers
Who was awarded contract HHSN261201000105C?
HHSN261201000105C was awarded to Rockland Immunochemicals Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.
How much is contract HHSN261201000105C worth?
The government has obligated $149,937 on HHSN261201000105C.
Was contract HHSN261201000105C competed?
The extent of competition for HHSN261201000105C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award